Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
4
×
life sciences
national blog main
amgen
boston blog main
boston top stories
cholesterol
inclisiran
national top stories
new york
new york blog main
new york top stories
regeneron pharmaceuticals
alnylam pharmaceuticals
biotech
fda
pcsk9
pcsk9 inhibitors
praluent
repatha
sanofi
the medicines co.
alirocumab
bempedoic acid
corticosteroids
data
deals
detroit
detroit blog main
detroit top stories
esperion therapeutics
evolocumab
ezetimibe
fluoroquinolones
ldl
mark timney
mt sinai hospital
novartis
peter wijngaard
prashant vaishnava
What
cholesterol
4
×
drug
medicines
fda
lowering
medco
twice
aces
acquire
agreed
announced
approved
big
billion
bringing
brings
cash
ceo
clears
closer
combo
company
compound
deal
esperion
esperion’s
filing
flexible
inched
inclisiran
key
levels
market
meant
medicine
morning
nasdaq
new
nod
novartis
Language
unset
4
×
Current search:
cholesterol
×
" clinical trials "
×
unset
×
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing